BRIACELL THERAPEUTICS CORP. (BCTX) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

The nearest decision zone is framed by support around 3.81 and resistance near 4.42. A move through resistance would be needed to materially improve the chart, while a break of support would keep the pressure side dominant. Pattern-based invalidation is near 14.01; losing that area would weaken the active formation considerably.

📊 Technical Summary

BRIACELL THERAPEUTICS CORP. (BCTX) finished the session at 4.18 (+3.98%). Short-term positioning has improved with price above the 50-day average, although the chart still needs to reclaim the 200-day average to fully repair the bigger picture. 20-day momentum is positive at +0.97%, with price is trading in the lower part of its roughly 52-week range (3.67–44.60), while ATR14 volatility is elevated at roughly 5.73% of price. RSI(14) is 50.5, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram remains negative, suggesting momentum is still on the softer side. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. From a pattern perspective, the main active signal is Double top. The most important nearby levels are support at 3.81 and resistance at 4.42. Clearing resistance would improve continuation odds, while slipping below support would weaken the present setup. On the fundamentals side, the latest snapshot shows Net income: -7.22M · EPS (basic): -2.58. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.

Explore more